Literature DB >> 23521092

Molecular orientation of factor VIIIa on the phospholipid membrane surface determined by fluorescence resonance energy transfer.

Hironao Wakabayashi1, Philip J Fay.   

Abstract

F (Factor) VIIIa binds to phospholipid membranes during formation of the FXase complex. Free thiols from cysteine residues of isolated FVIIIa A1 and A2 subunits and the A3 domain of the A3C1C2 subunit were labelled with PyMPO maleimide {1-(2-maleimidylethyl)-4-[5-(4-methoxyphenyl)-oxazol-2-yl]pyridinium methanesulfonate} or fluorescein (fluorescence donors). Double mutations of the A3 domain (C2000S/T1872C and C2000S/D1828C) were also produced to utilize Cys(1828) and Cys(1872) residues for labelling. Labelled subunits were reacted with complementary non-labelled subunits to reconstitute FVIIIa. Octadecylrhodamine incorporated into phospholipid vesicles was used as an acceptor for distance measurements between FVIII residues and membrane surface by fluorescence resonance energy transfer. The results of the present study indicate that a FVIII axis on a plane that intersects the approximate centre of each domain is orientated with a tilt angle of ~30-50° on the membrane surface. This orientation predicted the existence of contacts mediated by residues 1713-1725 in the A3 domain in addition to a large area of contacts within the C domains. FVIII variants where Arg(1719) or Arg(1721) were mutated to aspartate showed a >40-fold reduction in membrane affinity. These results identify possible orientations for FVIIIa bound to the membrane surface and support a new interaction between the A3 domain and the membrane probably mediated in part by Arg(1719) and Arg(1721).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23521092      PMCID: PMC4471871          DOI: 10.1042/BJ20130025

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

2.  Fluorescence quantum yields and their relation to lifetimes of rhodamine 6G and fluorescein in nine solvents: improved absolute standards for quantum yields.

Authors:  Douglas Magde; Roger Wong; Paul G Seybold
Journal:  Photochem Photobiol       Date:  2002-04       Impact factor: 3.421

3.  Spatial relationships between specific sites on reconstituted chloroplast proton adenosinetriphosphatase and the phospholipid vesicle surface.

Authors:  R A Cerione; R E McCarty; G G Hammes
Journal:  Biochemistry       Date:  1983-02-15       Impact factor: 3.162

4.  Methodology of the one-stage assay of Factor VIII (VIII:C).

Authors:  J Over
Journal:  Scand J Haematol Suppl       Date:  1984

5.  Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs.

Authors:  Gary E Gilbert; Randal J Kaufman; Andrew A Arena; Hongzhi Miao; Steven W Pipe
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

6.  Membrane-binding properties of the Factor VIII C2 domain.

Authors:  Valerie A Novakovic; David B Cullinan; Hironao Wakabayashi; Philip J Fay; James D Baleja; Gary E Gilbert
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

7.  The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Biochemistry       Date:  2005-01-18       Impact factor: 3.162

8.  The tertiary structure and domain organization of coagulation factor VIII.

Authors:  Betty W Shen; Paul Clint Spiegel; Chong-Hwan Chang; Jae-Wook Huh; Jung-Sik Lee; Jeanman Kim; Young-Ho Kim; Barry L Stoddard
Journal:  Blood       Date:  2007-10-26       Impact factor: 22.113

9.  The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.

Authors:  V P Mutucumarana; E J Duffy; P Lollar; A E Johnson
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

10.  Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine.

Authors:  G E Gilbert; D Drinkwater
Journal:  Biochemistry       Date:  1993-09-21       Impact factor: 3.162

View more
  10 in total

Review 1.  Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors:  Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

2.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

3.  Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

4.  Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.

Authors:  Jesper J Madsen; Y Zenmei Ohkubo; Günther H Peters; Johan H Faber; Emad Tajkhorshid; Ole H Olsen
Journal:  Biochemistry       Date:  2015-09-30       Impact factor: 3.162

5.  Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.

Authors:  Hironao Wakabayashi; Morgan Monaghan; Philip J Fay
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

Review 6.  Application of Fluorescence in Studying Therapeutic Enzymes.

Authors:  Zhaoshuai Wang; Caihong Li; Yinan Wei
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.

Authors:  Kenneth C Childers; Shaun C Peters; Pete Lollar; Harold Trent Spencer; Christopher B Doering; Paul C Spiegel
Journal:  Blood Adv       Date:  2022-06-14

8.  Environment-Sensitive Fluorescent Labelling of Peptides by Luciferin Analogues.

Authors:  Marialuisa Siepi; Rosario Oliva; Antonio Masino; Rosa Gaglione; Angela Arciello; Rosita Russo; Antimo Di Maro; Anna Zanfardino; Mario Varcamonti; Luigi Petraccone; Pompea Del Vecchio; Marcello Merola; Elio Pizzo; Eugenio Notomista; Valeria Cafaro
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

Review 9.  Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.

Authors:  Y Zenmei Ohkubo; Jesper J Madsen
Journal:  Thromb Haemost       Date:  2021-07-02       Impact factor: 5.249

10.  Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor.

Authors:  Estelle K Ronayne; Shaun C Peters; Joseph S Gish; Celena Wilson; H Trent Spencer; Christopher B Doering; Pete Lollar; P Clint Spiegel; Kenneth C Childers
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.